Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schafer

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Experimental Neurology|September 8, 2009
Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosisArie Neymotin, Susanne Petri, Noel Y Calingasan, et al.
Clinical Pharmacology in Drug Development|September 24, 2020
First-in-Human, Single- and Multiple-Ascending-Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase ModulatorYing Ye, Allison Gaudy, Peter Schafer, et al.
Psychosomatic Medicine|December 16, 2016
Chronic Stress and C-Reactive Protein in Mothers During the First Postpartum YearChristine M Guardino, Christine Dunkel Schetter, Calvin J Hobel, et al.
Cancer Chemotherapy and Pharmacology|December 4, 2012
Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administrationMatthew Hoffmann, Claudia Kasserra, Josephine Reyes, et al.
Maternal and Child Health Journal|July 30, 2014
The Preconception Stress and Resiliency Pathways Model: a multi-level framework on maternal, paternal, and child health disparities derived by community-based participatory researchSharon Landesman Ramey, Peter Schafer, Julia L DeClerque, et al.
Scientific Reports|January 19, 2020
Large-scale Analyses of Disease Biomarkers and Apremilast Pharmacodynamic EffectsIrina V Medvedeva, Matthew E Stokes, Dominic Eisinger, et al.
Respiratory Research|July 16, 2026
Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA<sub>1</sub> antagonism: exploratory analysis from a phase 2 trial of admilparantToby M Maher, Naftali Kaminski, Fang Wang, et al.
Cultural Diversity & Ethnic Minority Psychology|June 1, 2016
Risk, resilience, and depressive symptoms in low-income African American fathersOlajide N Bamishigbin, Christine Dunkel Schetter, Christine M Guardino, et al.
Arthritis Research & Therapy|June 8, 2010
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritisFiona E McCann, Andrew C Palfreeman, Melanie Andrews, et al.
Lupus Science & Medicine|March 17, 2021
Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosusFelice Rivellese, Sotiria Manou-Stathopoulou, Daniele Mauro, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Experimental Neurology|September 8, 2009
Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosisArie Neymotin, Susanne Petri, Noel Y Calingasan, et al.
Clinical Pharmacology in Drug Development|September 24, 2020
First-in-Human, Single- and Multiple-Ascending-Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase ModulatorYing Ye, Allison Gaudy, Peter Schafer, et al.
Psychosomatic Medicine|December 16, 2016
Chronic Stress and C-Reactive Protein in Mothers During the First Postpartum YearChristine M Guardino, Christine Dunkel Schetter, Calvin J Hobel, et al.
Cancer Chemotherapy and Pharmacology|December 4, 2012
Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administrationMatthew Hoffmann, Claudia Kasserra, Josephine Reyes, et al.
Maternal and Child Health Journal|July 30, 2014
The Preconception Stress and Resiliency Pathways Model: a multi-level framework on maternal, paternal, and child health disparities derived by community-based participatory researchSharon Landesman Ramey, Peter Schafer, Julia L DeClerque, et al.
Scientific Reports|January 19, 2020
Large-scale Analyses of Disease Biomarkers and Apremilast Pharmacodynamic EffectsIrina V Medvedeva, Matthew E Stokes, Dominic Eisinger, et al.
Respiratory Research|July 16, 2026
Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA<sub>1</sub> antagonism: exploratory analysis from a phase 2 trial of admilparantToby M Maher, Naftali Kaminski, Fang Wang, et al.
Cultural Diversity & Ethnic Minority Psychology|June 1, 2016
Risk, resilience, and depressive symptoms in low-income African American fathersOlajide N Bamishigbin, Christine Dunkel Schetter, Christine M Guardino, et al.
Arthritis Research & Therapy|June 8, 2010
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritisFiona E McCann, Andrew C Palfreeman, Melanie Andrews, et al.
Lupus Science & Medicine|March 17, 2021
Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosusFelice Rivellese, Sotiria Manou-Stathopoulou, Daniele Mauro, et al.
Pageof 6